AzTrials
AzTrials

BereavementADAPTNCT04929405

Pilot Testing ADAPT a Bereavement Care Intervention

A study testing ADAPT in people with Bereavement, run by East Carolina University at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Parental bereavement experiences are unique and require interventions adaptable to individual experiences.The web-based, multi-modal intervention, labeled ADAPT, incorporates varied self-management strategies including: A: Asking for assistance (option to connect with child's healthcare team); DA: Developing Adaptive… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Bereavement
What is being tested?
ADAPT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
2 sitesUnited States
Study dates
3 Mar 2021to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Biological parent and legal guardian of a deceased child who was 18 years old or younger at time of death
  • Cause of death of the deceased child is illness
  • Parent age 18 years or older at time of child's death
  • Ability to speak and read English sufficient to participate in the study

Who cannot join

  • Step-, foster-, grand- or fictive parent of a child who has died
  • Deceased child was unborn or over age 18 years at time of death
  • Deceased child was in legal custody of county or state jurisdiction
  • Cause of child's death was in utero or traumatic
  • Parent age less than 18 years
  • Inability to speak and read English sufficient to participate

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Akron Children's Hospital

    Akron, Ohio, 44308

  • Cardinal Glennon Childrens Hospital

    St Louis, Missouri, 63104

Other trials in United States

About this study

Official title: Pilot-Testing a Theoretically Based Digital Intervention for Bereaved Parents (ADAPT)

Parental bereavement experiences are unique and require interventions adaptable to individual experiences.The web-based, multi-modal intervention, labeled ADAPT, incorporates varied self-management strategies including: A: Asking for assistance (option to connect with child's healthcare team); DA: Developing Adaptive ability (self-management tools: e.g. stress reduction, legacy building); P: Accessing Pertinent online resources (grief support networks/websites); and T: Tracking one's health (self-administered surveys for grief, sleep, anxiety, and depression). A quasi-experimental, treatment-only design will be used for this study. The hypothesis is that the ADAPT intervention will promote positive adaptation to influence grief integration and consequently affect health outcomes (improved sleep and social interactions, and decreased anxiety and depressive symptoms).The purpose of this study is to describe the nature and degree of clinical benefit of the intervention on bereaved parents' health outcomes.

Read the detailed description

ADAPT, is multi-modal intervention that promotes a targeted approach to individual parental bereavement experiences. ADAPT is based on the theoretical foundations of the Adaptive Leadership (AL) framework. ADAPT, incorporates varied self-management strategies including: A: Asking for assistance (option to connect with child's healthcare team); DA: Developing Adaptive ability (self-management tools: e.g. stress reduction, legacy building); P: Accessing Pertinent online resources (grief support networks/websites); and T: Tracking one's health (self-administered surveys for grief, sleep, anxiety, and depression). Parents can download ADAPT on any digital device (phones/computers) using weblink.

  1. Study Purpose and Objective(s)

The purpose of this study is to describe the nature and degree of clinical benefit of the intervention on bereaved parents' health outcomes. The Specific Aims are:

Aim 1: Assess the acceptability and feasibility of the ADAPT intervention components. Acceptability will be assessed with a modified standardized acceptability survey and cognitive interviews. Feasibility will be assessed by accrual (recruitment), attrition, and intervention engagement (i.e., frequency, duration, and interaction). Intervention engagement data will be obtained via Google analytics and cognitive interviews.

Hypothesis 1.1: ADAPT is acceptable to participants (> 80% acceptability based on survey).

Hypothesis 1.2: Delivery of ADAPT is feasible in terms of accrual (N=30), attrition (15%), and intervention engagement (minimally accessed 3 times for >15 minutes and used at least 2 self-management strategies) Aim 2: Determine if the use of the ADAPT intervention components results in a clinically meaningful change in grief integration (Brief Grief Questionnaire) and bereaved parents' health outcomes (Visual Analogue Scale for overall health and PROMIS surveys for sleep, social isolation, anxiety, and depression). Hypothesis 2.1: After completing the ADAPT intervention, participants will demonstrate improvement in health outcome scores when compared to baseline (T0).

Design: quasi-experimental, treatment-only design. Sample: N=35 parents of children who have died while being followed for care at either Akron Children's Hospital or Cardinal Glennon Children's hospital.

Recruitment: Participants will be recruited into two groups. Group 1 will be parents whose child died 4 weeks (+ 2 weeks) prior; Group 2 will be parents whose child died three months (+/- 2 weeks) prior to enrollment. Either a mother or a father for any one child will be recruited.

For both the groups, a Study Information Sheet will be included in each bereavement packet sent or mailed home, at either 4 week (group 1) or 3 months (group 2) after the child has died. This Study Information Sheet will have a study-specific phone number and email address for a clinical research coordinator, through which the parent can immediately opt in or opt out. If there is no response following one to two weeks after the bereavement packet was sent, the bereaved parents will be contacted by study staff via telephone to assess interest, discuss the study, and answer any questions they may have. If the parent agrees to participate, econsent will be completed using REDCap. After completing the econsent, participants will have access to ADAPT and will be provided a REDCap survey link to allow self-completion of baseline questionnaires (T0) (see Table 1). Three months after completing the intervention (T1), participants will again be provided a REDCap survey link to post-intervention questionnaires (see Table.1). At that time, a semi-structured cognitive interview with participants will be scheduled. The interviews will be conducted via telephone and will be recorded, transcribed, and verified for accuracy by the study team.

Conditions
Bereavement
Being tested
ADAPT
Keywords
Bereavement, Palliative Care, Web-based Intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ADAPTBehavioural

    ADAPT, is multi-modal to promote a targeted approach to individual parental bereavement experiences and is not time or geographically limited. ADAPT is based on the theoretical foundations of the Adaptive Leadership (AL) framework. Our interdisciplinary team developed a web-based, multi-modal intervention, labeled ADAPT, that incorporates varied self-management strategies including: A: Asking for assistance (option to connect with child's healthcare team); DA: Developing Adaptive ability (self-management tools: e.g. stress reduction, legacy building); P: Accessing Pertinent online resources (grief support networks/websites); and T: Tracking one's health (self-administered surveys for grief, sleep, anxiety, and depression). Parents can download ADAPT on any digital device (phones/computers) using a Quick Response (QR) bar code or weblink.

Study groups in NCT04929405
Study groupRoleWhat they receive
Intervention groupExperimentalThis group has access to the intervention (website for bereaved parents)
Receives: Behavioral: ADAPT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment

    Recruited 35 participants in the study timeframe

    Measured: 3 months

  2. Retention

    Participants complete surveys at pre and post intervention.

    Measured: 3 months

Secondary outcomes (5)
  1. Sleep

    Change in the Patient-Reported Outcomes Measurement Information System (PROMIS) sleep scores from baseline to 3 months. The final score for these PROMIS measures is represented by the T-score, a standardized score with a mean of 50 and a standard deviation (SD) of 10. Scoring will be completed by uploading deidentified data to the Health Measures Scoring Service using the General and Clinical reference population.

    Measured: 3 months

  2. Grief

    Change in grief scores of the Brief Grief Questionnaire from baseline to 3 months. If the participants score 4 or above they need full evaluation.

    Measured: 3 months

  3. Social isolation

    Change in the Patient-Reported Outcomes Measurement Information System (PROMIS) social isolation scores from baseline to 3 months. The final score for these PROMIS measures is represented by the T-score, a standardized score with a mean of 50 and a standard deviation (SD) of 10. Scoring will be completed by uploading deidentified data to the Health Measures Scoring Service using the General and Clinical reference population.

    Measured: 3 months

  4. Anxiety

    Change in the Patient-Reported Outcomes Measurement Information System (PROMIS) anxiety scores from baseline to 3 months. The final score for these PROMIS measures is represented by the T-score, a standardized score with a mean of 50 and a standard deviation (SD) of 10. Scoring will be completed by uploading deidentified data to the Health Measures Scoring Service using the General and Clinical reference population.

    Measured: 3 months

  5. Depression

    Change in the Patient-Reported Outcomes Measurement Information System (PROMIS) depression scores from baseline to 3 months. The final score for these PROMIS measures is represented by the T-score, a standardized score with a mean of 50 and a standard deviation (SD) of 10. Scoring will be completed by uploading deidentified data to the Health Measures Scoring Service using the General and Clinical reference population.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2021
  2. Study start3 Mar 2021
  3. Primary completion31 Dec 2021
  4. Study completion31 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04929405
Sponsor's protocol ID
UMCIRB 19-001984
Acronym
ADAPT
Status last verified
Mar 2022
First submitted
25 Aug 2020
Last updated
22 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing ADAPT in people with Bereavement, run by East Carolina University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recruitment (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Mar 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in